Guangzhou Kingmed Diagnostics Group Co Ltd (Kingmed) is an independent clinical testing laboratory that develops and commercializes medical, pathological and genomic tests. The company offers investment services, consulting services, information system integration services, water quality testing services, environmental services, biotechnology transfer services, food services, hygiene testing and scientific research services. It also offers blood tests including immunology, hemostasis, and clinical chemistry to mass spectrometry, and gene-based and molecular tests. Kingmed is headquartered in Guangzhou, Guangdong, China.
Headquarters
China
Address
No.10 Luoxuan 3th Road, International Bio Island, Guangzhou, Guangdong, 510000
Website
www.kingmed.com.cn
Telephone
86 20 29196326
No of Employees
14,411
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
603882 (SHA)
Revenue (2022)
$2.3B
29.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
24%
(2022 vs 2021)
Market Cap*
$2.8B
Net Profit Margin (2022)
XYZ
-4.3%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Services |
|---|
| Clinical Diagnostics |
| Clinical Trials |
| Health Management |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Guangzhou Kingmed Diagnostics Group Co Ltd | Dian Diagnostics Group Co Ltd | Daan Gene Co Ltd | Medicalsystem Biotechnology Co Ltd | SonoScape Medical Corp |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Guangzhou | Hangzhou | Guangzhou | Ningbo | Shenzhen |
| State/Province | Guangdong | Zhejiang | Guangdong | Zhejiang | Guangdong |
| No. of Employees | 14,411 | 13,128 | 3,580 | 2,473 | 2,334 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Liang Yaoming | General Manager; Chairman | Executive Board | 2015 | 59 |
| Hao Bixi | Chief Financial Officer; Deputy General Manager; Secretary; Director | Executive Board | 2015 | 53 |
| Wang Linglai | Deputy General Manager; Director | Executive Board | 2020 | 51 |
| Yan Ting | Deputy General Manager; Director | Executive Board | 2015 | 54 |
| Yang Wanfeng | Deputy General Manager | Senior Management | 2018 | 46 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer